The NHS in the UK is planning to sell anonymized patient data to raise funds, spark research and improve patient outcomes – a controversial move set to benefit companies like Palantir Technologies. Critics are concerned about compromised patient confidentiality and security risks. NHS has an opt-out page for those not wishing to share data and has pledged not to sell data to insurance or marketing firms.
Few adolescents receive gender-affirming care: Research
A study found that less than 1 in 1,000 adolescents received gender-affirming medication from 2018 to 2022. Out of over 5 million patients surveyed, 926
